Ad is loading...
MEMQX
Price
$7.68
Change
-$0.03 (-0.39%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

MEMQX vs RNWFX

Header iconMEMQX vs RNWFX Comparison
Open Charts MEMQX vs RNWFXBanner chart's image
Mercer Emerging Markets Equity Y3
Price$7.68
Change-$0.03 (-0.39%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
MEMQX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEMQX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEMQX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. MEMQX (988M). MEMQX pays higher dividends than RNWFX: MEMQX (2.35) vs RNWFX (1.51). MEMQX was incepted earlier than RNWFX: MEMQX (13 years) vs RNWFX (23 years). MEMQX is a more actively managed with annual turnover of: 95.00 vs. RNWFX (32.00). MEMQX has a lower initial minimum investment than RNWFX: MEMQX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. MEMQX (6.33). RNWFX return over 5 years is better than : 17.17 vs. MEMQX (-7.79).
MEMQXRNWFXMEMQX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD2.4007.09934%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets988M60.9B2%
Annual Yield % from dividends2.351.51156%
Returns for 1 year6.3311.5455%
Returns for 3 years-26.63-14.55183%
Returns for 5 years-7.7917.17-45%
Returns for 10 years-10.2441.00-25%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics